Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33961040.
- Also identified by DOI 10.1001/jamanetworkopen.2021.7728 and PMC identifier 8105747.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines the association of <i>BRCA1</i> and <i>BRCA2</i> with tumor mutation burden and response to immune checkpoint inhibitors.
Medical subject headings
- BRCA1 Protein
- BRCA2 Protein
- Immune Checkpoint Inhibitors